Headlines

Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.

Active Watch List : Exelon Corporation (NYSE:EXC), Archer-Daniels-Midland Company (NYSE:ADM), Barracuda Networks, Inc. (NYSE:CUDA), Pearson plc (NYSE:PSO), Vodafone Group Plc (ADR) (NASDAQ:VOD)

Mark Doerr03 mins

Pepco Holdings Inc. is one step closer to its $6.8 billion merger with Chicago-based Exelon Corporation (NYSE:EXC), winning approval from the Virginia State Corporation Commission. The proposed merger, first announced in April, still needs approval from the Federal Energy Regulatory Commission, the Delaware Public Service Commission, the Public Service Commission of the District of Columbia,…

Read More

Hot Stock List : Staples, Inc. (NASDAQ:SPLS), Delta Air Lines, Inc. (NYSE:DAL), Oi SA (NYSE:OIBR), PrivateBancorp, Inc. (NASDAQ:PVTB), Intel Corporation (NASDAQ:INTC)

Mark Doerr03 mins

Staples, Inc. (NASDAQ:SPLS) on Sept. 23 announced the opening of a new health and fitness center at its global corporate headquarters, in Framingham, Massachusetts, the latest in a series of updates to the campus, including going smoke-free, a new, healthier cafeteria and a redesigned, more open and collaborative floor plan, both designed by Business Interiors…

Read More

Hot Alert : Intel Corporation (NASDAQ:INTC), Office Depot, Inc. (NASDAQ:ODP), Westwood Holdings Group Inc. (NYSE:WHG), Cerus Corporation (NASDAQ:CERS), TESSCO Technologies Inc. (NASDAQ:TESS)

Mark Doerr03 mins

Intel Corporation (NASDAQ:INTC) currently dominates the $13bn server market with ARM’s partners having very little share. However, “Intel is unlikely to sit quietly and watch ARM and its partners eat into its very profitable server business, Eoin Lambe at Liberum Capital pointing to one of the key risks of ARM’s diversification strategy. Intel Corporation (NASDAQ:INTC)…

Read More

Top Stories : Sequenom Inc. (NASDAQ:SQNM), Chesapeake Energy Corporation (NYSE:CHK), Delcath Systems, Inc. (NASDAQ:DCTH), Appliance Recycling Centers of America Inc. (NASDAQ:ARCI), HMST

Mark Doerr03 mins

Sequenom, Inc. (NASDAQ:SQNM) and Isis Innovation Ltd. today jointly announced that Sequenom has purchased noninvasive prenatal testing intellectual property from Isis Innovation, for $14.55 million, which includes $3.2 million as the final royalty payment due to Isis under the prior agreement and the waiver of $2.1 million in paid legal fees that Isis owed to…

Read More

Stock Runners : TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), EMC Corporation (NYSE:EMC), Nabors Industries Ltd. (NYSE:NBR), BioMed Realty Trust (NYSE:BMR), Old Republic International (NYSE:ORI)

Mark Doerr03 mins

Analysts at Nomura initiated coverage on shares of Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) in a research note on Thursday, June 26th. They set a “buy” rating and a $9.00 price target on the stock. Four equities research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and…

Read More

Hot News : Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), CalAmp Corp. (NASDAQ:CAMP), Phillips 66 (NYSE:PSX), HEICO Corporation (NYSE:HEI), BlackBerry Ltd (NASDAQ:BBRY)

Mark Doerr03 mins

Alder BioPharmaceuticals (NASDAQ:ALDR) announced data from the proof-of-concept clinical trial of ALD403 published in the October 6, 2014 issue of Lancet Neurology demonstrates that ALD403 met the primary study endpoint and is effective for the preventative treatment of migraine. ALD403 is Alder’s lead clinical candidate targeting the calcitonin gene-related peptide, or CGRP, for migraine prevention….

Read More
Home